Boromenthol

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT BOROMENTHOL

Composition:

Active ingredients: boric acid, menthol;

1 g of ointment contains 0.05 g of boric acid and 0.005 g of menthol;

Excipient: white soft paraffin.

Pharmaceutical form. Ointment.

Main physicochemical properties: ointment of white or light yellow color with a characteristic odor. The ointment should be homogeneous in appearance.

Pharmacotherapeutic group.
Boric acid preparations. ATC code D08AD.

Pharmacological properties.

Pharmacodynamics. A combined preparation for topical use. Exerts antiseptic and analgesic effects.

Pharmacokinetics. When applied topically, Boromenthol is practically not absorbed into the systemic circulation.

Clinical characteristics.

Indications.

Skin itching, neuralgias, rhinitis.

Contraindications.

Hypersensitivity to the components of the drug, severe renal function impairment.

Special precautions.

The drug is intended for external use only. Avoid contact with eyes; do not apply the drug to large areas of skin; do not rub into nostrils.

Interaction with other medicinal products and other forms of interaction.

Not established.

Special precautions for use.

Do not apply to the nasal mucosa.

Use during pregnancy or breastfeeding.

The drug is contraindicated during pregnancy. During breastfeeding, use only if the expected benefit to the woman outweighs the potential risk to the infant.

Ability to affect reaction speed when driving vehicles or operating machinery.

The drug does not affect reaction speed when driving vehicles or operating machinery.

Method of Administration and Dosage.

Apply the ointment in small amounts to affected skin areas; in case of rhinitis, apply to the skin of the nasal wings and gently rub in. The frequency of application and duration of treatment depend on the therapeutic effect achieved and the drug's tolerability.

Children.

Contraindicated in children under 3 years of age. In this age group, reflex respiratory arrest is possible.

Overdose.

With prolonged use of topical agents on large affected skin areas, symptoms of acute poisoning may occur, such as nausea, vomiting, diarrhea, circulatory disturbances, central nervous system depression, decreased body temperature, erythematous rash, shock, coma. With prolonged application, symptoms of chronic intoxication may develop: exhaustion, stomatitis, eczema, local tissue edema, menstrual cycle disturbances, anemia, seizures, alopecia.

Treatment is symptomatic. Hemotransfusion, hemodialysis, and peritoneal dialysis are indicated. In case of accidental ingestion, perform gastric lavage via tube, administer saline laxatives and enterosorbents (activated charcoal) orally, and provide symptomatic therapy. In cases of severe poisoning, take measures to support vital functions of the body.

Side effects.

Allergic reactions are possible, including skin redness, itching, urticaria, rash, swelling, contact dermatitis, development of anaphylactic reactions including shock, and epithelial desquamation. When applied to large areas of skin, vomiting, diarrhea, headache, confusion, and renal failure are possible.

Shelf life. 2 years.

Storage conditions.

Store at a temperature not exceeding 25 °C.

Keep out of reach of children.

Packaging.

25 g in aluminum tubes, in cardboard boxes or without cardboard boxes.

Availability. Over-the-counter.

Manufacturer/Marketing Authorization Holder.

LLC "Ternofarm".

Manufacturer's address and location of its business activity / Marketing Authorization Holder's address.

4, Fabrychna St., Ternopil, Ukraine, 46010.